Rcix)inbinanC DMA Advisoiy Committee - 6/9-10/94 
Liaison Representative: 
Daniel Jones, National Endowment for the Humanities 
National Institutes of Health staff: 
Niles Bemick, OD 
R. Michael Blaese, NCI 
Diane Bronzert, NCI 
Sarah Carr, OD 
Barry Goldspiel, CC 
Toby Hecht, NQ 
Christine Ireland, OD 
Susan Jenks, NQ 
Becky Ann Lawson, OD 
Johnson Liu, NHLBI 
Catherine McKeon, NIDDK 
Koichi Miyamura, NHLBI 
Joan Porter, OD 
Muzaffar Quazilbash, NHLBI 
Mallika Sekhar, NHLBI 
Thomas Shih, OD 
Bernard Talbot, NCRR 
Chris Walsh, NHLBI 
Debra Wilson, OD 
Neal Young, NHLBI 
Others: 
Munir Abdullah, Glaxo, Inc. 
Estuardo Aguilar, Baylor College of Medicine 
W. French Anderson, University of Southern California 
Mary Helen Binger, Hoffmann-LaRoche, Inc. 
Bridget Binko, Cell Genesys, Inc. 
Robert Boyd, Knight-Ridder, Inc. 
Ronna Campbell, University of Pittsburgh 
Jeff Carey, Genetic Therapy, Inc. 
Rachel Carle, Genzyme Corporation 
Barry Carter, Targeted Genetics Corporation 
Jan Chappell, Genetic Therapy, Inc. 
Yawen Chiang, Genetic Therapy, Inc. 
Lori Clarke, Genetic Therapy, Inc. 
Richard Cote, University of Southern California 
David Curiel, University of Alabama 
Karen Darcy, Magenta Corporation 
Albert Deisseroth, MD Anderson Cancer Center 
[3101 
Recombinant DNA Research, Volume 19 
